Official: Genmab enters elite index
![Foto: Genmab/ PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article6255488.ece/ALTERNATES/schema-16_9/genmab-copenhagen-office.jpg)
As detailed previously here on Medwatch, Genmab will become the newest member of the C20 CAP index. The inclusion of Genmab sees another Danish life science company, Lundbeck, leaving the top 20, the Copenhagen Stock Exchange reveals.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Genmab CEO expects profitable years ahead
For abonnenter
Genmab improves guidance following milestone
For abonnenter
Biotech chiefs believe in Genmab effect
For abonnenter